Rating History for NGM Biopharmaceuticals (NGM) by Raymond James
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 3/12/2024 | Steven Seedhouse | Downgrade | Market Perform (Outperform) |
N/A (N/A) |
1.53 (1.54) |
0.65% | Details |
 |
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
